These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25927440)

  • 1. Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer.
    Naipal KA; Raams A; Bruens ST; Brandsma I; Verkaik NS; Jaspers NG; Hoeijmakers JH; van Leenders GJ; Pothof J; Kanaar R; Boormans J; van Gent DC
    PLoS One; 2015; 10(4):e0126029. PubMed ID: 25927440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo destabilization and functional defects of the xeroderma pigmentosum C protein caused by a pathogenic missense mutation.
    Yasuda G; Nishi R; Watanabe E; Mori T; Iwai S; Orioli D; Stefanini M; Hanaoka F; Sugasawa K
    Mol Cell Biol; 2007 Oct; 27(19):6606-14. PubMed ID: 17682058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair.
    Sugasawa K; Ng JM; Masutani C; Iwai S; van der Spek PJ; Eker AP; Hanaoka F; Bootsma D; Hoeijmakers JH
    Mol Cell; 1998 Aug; 2(2):223-32. PubMed ID: 9734359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
    Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
    Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression.
    Chen Z; Yang J; Wang G; Song B; Li J; Xu Z
    Cancer Res; 2007 May; 67(10):4578-85. PubMed ID: 17510383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated NER expressions of XPF and XPC associated with smoking are involved in the recurrence of bladder cancer.
    Qiu J; Wang X; Meng X; Zheng Y; Li G; Ma J; Ye G; Li Y; Li J
    PLoS One; 2014; 9(12):e115224. PubMed ID: 25535740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XPC deficiency is related to APE1 and OGG1 expression and function.
    de Melo JT; de Souza Timoteo AR; Lajus TB; Brandão JA; de Souza-Pinto NC; Menck CF; Campalans A; Radicella JP; Vessoni AT; Muotri AR; Agnez-Lima LF
    Mutat Res; 2016; 784-785():25-33. PubMed ID: 26811994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein.
    Nishi R; Okuda Y; Watanabe E; Mori T; Iwai S; Masutani C; Sugasawa K; Hanaoka F
    Mol Cell Biol; 2005 Jul; 25(13):5664-74. PubMed ID: 15964821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPC beyond nucleotide excision repair and skin cancers.
    Zebian A; Shaito A; Mazurier F; Rezvani HR; Zibara K
    Mutat Res Rev Mutat Res; 2019; 782():108286. PubMed ID: 31843141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XPC deficiency leads to centrosome amplification by inhibiting BRCA1 expression upon cisplatin-mediated DNA damage in human bladder cancer.
    Wang H; Huang Y; Shi J; Zhi Y; Yuan F; Yu J; Chen Z; Yang J
    Cancer Lett; 2019 Mar; 444():136-146. PubMed ID: 30579971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of arsenic on nucleotide excision repair: XPC function, protein level, and gene expression.
    Nollen M; Ebert F; Moser J; Mullenders LH; Hartwig A; Schwerdtle T
    Mol Nutr Food Res; 2009 May; 53(5):572-82. PubMed ID: 19382146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
    Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
    Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow accumulation of mutations in Xpc-/- mice upon induction of oxidative stress.
    Melis JP; Kuiper RV; Zwart E; Robinson J; Pennings JL; van Oostrom CT; Luijten M; van Steeg H
    DNA Repair (Amst); 2013 Dec; 12(12):1081-6. PubMed ID: 24084170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XPC is essential for nucleotide excision repair of zidovudine-induced DNA damage in human hepatoma cells.
    Wu Q; Beland FA; Chang CW; Fang JL
    Toxicol Appl Pharmacol; 2011 Mar; 251(2):155-62. PubMed ID: 21192964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of four novel XPC mutations in two xeroderma pigmentosum complementation group C patients and functional study of XPC Q320X mutant.
    Gu Y; Chang X; Dai S; Song Q; Zhao H; Lei P
    Gene; 2017 Sep; 628():162-169. PubMed ID: 28669926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.
    Khan SG; Yamanegi K; Zheng ZM; Boyle J; Imoto K; Oh KS; Baker CC; Gozukara E; Metin A; Kraemer KH
    Hum Mutat; 2010 Feb; 31(2):167-75. PubMed ID: 19953607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The UV-damaged DNA binding protein mediates efficient targeting of the nucleotide excision repair complex to UV-induced photo lesions.
    Moser J; Volker M; Kool H; Alekseev S; Vrieling H; Yasui A; van Zeeland AA; Mullenders LH
    DNA Repair (Amst); 2005 May; 4(5):571-82. PubMed ID: 15811629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of XPC: implications in cancer and oxidative DNA damage.
    Melis JP; Luijten M; Mullenders LH; van Steeg H
    Mutat Res; 2011; 728(3):107-17. PubMed ID: 21763452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.
    Barckhausen C; Roos WP; Naumann SC; Kaina B
    Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.